NCT00904280View on ClinicalTrials.gov

Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy

PHASE3CompletedINTERVENTIONAL
Enrollment

239

Participants

Timeline

Start Date

March 31, 2001

Primary Completion Date

July 31, 2003

Study Completion Date

July 31, 2003

Conditions
Cancers, PainLower Back Pain
Interventions
DRUG

Oxymorphone ER

Open label

Trial Locations (1)

Unknown

Arizona Clinical Research Center, Tucson

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY